BarbriSFCourseDetails
  • videocam Live Webinar with Live Q&A
  • calendar_month March 19, 2026 @ 1:00 PM E.T.
  • signal_cellular_alt Intermediate
  • card_travel ERISA
  • schedule 90 minutes

Pharmacy Benefit Manager Contracting for Fully Insured and Self-Funded Group Plans

BarbriPdBannerMessage

About the Course

Introduction

This CLE course will provide employee benefits counsel guidance on applicable rules and recent legislative developments on pharmacy benefit manager (PBM) contracting and offer strategies for negotiating and drafting PBM agreements for employee health plans. The panel will discuss the impact of the One Big Beautiful Bill Act (OBBBA) and other recent legislation, how to maximize prescription coverage savings, and how to draft agreements that guarantee transparency and plan sponsor oversight and avoid hidden fees.

Description

Prescription drug expenses have increased more than any other healthcare category over the past 10 years. PBMs can help employers with self-funded plans control prescription costs, but PBM contracts must be carefully negotiated and drafted to protect the plan sponsor's—rather than the PBM's—interests.

OBBBA provides a few provisions aimed at PBMs but proposed legislation for significant reform is pending to further transparency, fees, and other key items. Counsel must thoroughly understand the complexities of prescription drug pricing and PBM contracting to control costs, avoid hidden fees, and maximize prescription drug benefit performance.

Listen as our authoritative panel discusses recent developments for PBMs and offers strategies for negotiating and drafting PBM contracts. The panel will discuss how to maximize prescription coverage savings, draft agreements that guarantee transparency and plan sponsor oversight, and avoid hidden fees.

Presented By

Theresa C. Carnegie
Member
Mintz Levin Cohn Ferris Glovsky & Popeo PC

Ms. Carnegie has extensive experience advising clients on all aspects of the pharmaceutical supply chain. Her practice involves advising industry stakeholders on a range of business, legal, transactional, and compliance matters. Ms. Carnegie combines her multilayered industry knowledge with a deep understanding of applicable federal and state legal frameworks, in particular federal and state fraud and abuse laws. She provides clients with strategic counseling and creative business modeling that considers legal restrictions and regulatory risk in light of innovation and business goals.

Lauren M. Moldawer
Member
Mintz Levin Cohn Ferris Glovsky & Popeo PC

Ms. Moldawer's practice focuses on advising clients through complex health care transactions and regulatory matters. She has served as health care counsel on numerous private equity and strategic transactions, including mergers and acquisitions, joint ventures, affiliations, and investments involving pharmacies, PBMs, physician practices, long-term care facilities, third party payors, value-based contracting entities, nurse staffing companies, and health care technology firms. Ms. Moldawer's deal work is complimented by her regulatory practice, which primarily focuses on advising pharmacies, PBMs, managed care organizations and other clients in the payor space. Drawing from her experience working for the Federal Coordinated Health Care Office (the “Duals Office”) within the Centers for Medicare & Medicaid Services (“CMS”), she is able to provide practical advice to clients on regulatory and compliance issues relating to Medicare Advantage, Medicare Part D and Medicaid. Ms. Moldawer has advised clients on Medicare Advantage and Medicare Part D applications, audit appeals, contract negotiations, Medicaid managed care RFPs, and payment issues.

Stephen P. Wilkes
Chief Legal Officer, Partner
The Wagner Law Group, LLP

Mr. Wilkes heads the firm's Investment Management Law practice. He also is a Practice Group leader for the firm’s ERISA Fiduciary Compliance and Independent Fiduciary practices. Mr. Wilkes advises a national client base of mutual funds, CIFs, private funds, registered investment advisers, insurance companies, broker dealers, wealth management firms, banks, trust companies, third-party platform providers, Taft Hartley Funds  and plan sponsors on ERISA, tax, and related securities law issues. He counsels clients regarding ERISA fiduciary and prohibited transaction issues, investment matters, alternative investments, securities law issues, federal tax issues, and the employee benefits aspects of bankruptcy and related financial restructurings, reorganizations and liquidations. Mr. Wilkes interacts with regulatory agencies and congressional staff on legislative and regulatory issues involving the DOL, SEC, IRS, PBGC and OCC. He has extensive experience in handling audits by the DOL, the IRS, and the SEC. He gives advice and counseling with respect to retirement plan services agreements, investment management agreements, DOL regulations, SEC regulations, federal legislative activity, qualified employee pension plans, ERISA litigation, Collective Investment Funds, off-shore investment advisers, Sales and Marketing Distribution Agreements and Wrap-Fee Programs.

Credit Information
  • This 90-minute webinar is eligible in most states for 1.5 CLE credits.


  • Live Online


    On Demand

Date + Time

  • event

    Thursday, March 19, 2026

  • schedule

    1:00 PM E.T.

I. Overview of PBM contracting

II. Impact of OBBBA and recently proposed legislation

III. Selecting PBMs

IV. Negotiating agreements

V. Pricing and fees

VI. Monitoring PBMs

The panel will review these and other key issues:

  • Ensuring flexibility to remain nimble in a rapidly changing marketplace
  • Avoiding drafting pitfalls that increase prescription benefit costs
  • Developing effective RFPs to compare and select PBMs
  • Conducting an audit of a PBM contract and benefit plan